Involvement of multiple protein kinases in cPLA2 phosphorylation, arachidonic acid release, and cell death in in vivo and in vitro models of 1-methyl-4-phenylpyridinium-induced parkinsonism - The possible key role of PKG

Journal of Neurochemistry

Volumn 110, Issue 1, 2009, Pages 307-317

  Chalimoniuk, Malgorzata ^a   Stolecka, Anna ^a,b   Ziemińska, Elzbieta ^a   Stpień, Adam ^c   Langfort, Josef ^a,b   Strosznajder, Joanna B ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b INSTITUTE OF SPORT SCIENCES   (Poland)

^c MILITARY INSTITUTE OF MEDICINE   (Poland)

Author keywords

Arachidonic acid release; Cyclic GMP dependent kinase protein; Cytosolic phospholipase A2; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 2 OXO 1,1,1 TRIFLUORO 6,9,12,15 HENEICOSATETRAENE; ARACHIDONIC ACID; CALCIUM ION; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; CYTOSOLIC PHOSPHOLIPASE A2; DELTA BROMOMETHYLENE ALPHA (1 NAPHTHYL) DELTA VALEROLACTONE; GF 102610X; KT 5823; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; UO 126;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM CELL LEVEL; CELL VIABILITY; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; MESENCEPHALON; MOUSE; NONHUMAN; PARKINSONISM; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANIMALS; ARACHIDONIC ACID; CALCIUM; CATALYTIC DOMAIN; CELL DEATH; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; MICE; MICE, INBRED C57BL; MODELS, BIOLOGICAL; NERVE DEGENERATION; NITRIC OXIDE SYNTHASE TYPE I; PARKINSONIAN DISORDERS; PC12 CELLS; PHOSPHOLIPASES A2, CYTOSOLIC; PROTEIN KINASE C; RATS; SERINE; SIGNAL TRANSDUCTION; SUBSTANTIA NIGRA;

TRIFLUORO;

EID: 67449116584     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06147.x     Document Type: Article

References (51)

1. Bazan N. G. (1998) The neuromessenger platelet-activating factor in plasticity and neurodegeneration. Prog. Brain Res. 118, 281 291. (Pubitemid 28530674)
2. Bazan N. G., Colangelo V. Lukiw W. J. (2002) Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 68-69, 197 210. (Pubitemid 35247397)
3. Bligh E. G. Dyer W. J. (1959) A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911 917.
4. Bloem B. R., Irwin I., Buruma O. J. S., Haan J., Roos R. A. C., Tetrud J. W. Langston J. (1990) The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease. J. Neurol. Sci. 97, 273 293. (Pubitemid 20231246)
5. Bove J., Prou D., Perier C. Przedborski S. (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2, 484 494. (Pubitemid 41444882)
6. Canals S., Casarejos M. J., de Bernardo S., Rodriguez-Marti E. Mena M. A. (2000) Glutathione depletion switches nitric oxide neurotrophic effects to cell death in midbrain cultures: implications for Parkinson's disease. J. Neurochem. 79, 1183 1195.
7. Canals S., Casarejos M. J., de Bernardo S., Rodriguez-Marti E. Mena M. A. (2003) Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipogenase. J. Biol. Chem. 278, 21542 21549. (Pubitemid 36792552)
8. 2 expressed in insect cells and present in human monocytes. J. Biol. Chem. 271, 6987 6997. (Pubitemid 26104131)
9. Chalimoniuk M., Langfort J., Lukacova N. Marsala J. (2004) Upregulation of expression and activity guanylyl cyclase in MPTP animals model Parkinson's disease. Biochem. Biophys. Res. Commun. 324, 118 126. (Pubitemid 39311468)
10. Chalimoniuk M., Głowacka J., Zabielna A., Eckert A. Strosznajder J. B. (2006a) Nitric oxide alters arachidonic acid turnover in brain cortex synaptoneurosomes. Neurochem. Int. 48, 1 8. (Pubitemid 41774273)
11. Chalimoniuk M., Lukacova N., Marsala J. Langfort J. (2006b) Midbrain alterations in MPTP model of Parkinson disease of nNOS and CG expressions and activities in mouse. Neuroscience 324, 118 126.
12. 2 reveals a novel topology and catalytic mechanism. Cell 97, 349 360. (Pubitemid 29214591)
13. 2 phosphorylation and translocation. BMC Biochem. 3, 30 42.
14. 2 and its role in brain tissue. J. Neurochem. 69, 889 901. (Pubitemid 27364808)
15. 2 in neurodegeneration. Neurochem. Int. 3, 517 522. (Pubitemid 27187221)
16. Geijsen N., Dijkers P. F., Lammers J. J., Koenderman L. Coffer P. J. (2000) Cytokine-mediated cPLA(2) phosphorylation is regulated by multiple MAPK family members. FEBS Lett. 471, 83 88. (Pubitemid 30173298)
17. 2 activity. J. Leukoct. Biol. 65, 330 336. (Pubitemid 29109704)
18. 2 is required for macrophage arachidonic acid release by agonists that do and do not mobilize calcium. Novel role of mitogen-activated protein kinase pathways in cytosolic phospholipase A2 regulation. J. Biol. Chem. 275, 20146 20156. (Pubitemid 30441626)
19. Gow A. J., Chen Q., Hess D. T., Day B. J., Ischiropoulos H. Stamler J. S. (2002) Basal and stimulated protein S-nitrosylation in multiple cell types and tissues. J. Biol. Chem. 277, 9637 9640. (Pubitemid 34968060)
20. 2 by MNK1-related protein kinase. J. Biol. Chem. 275, 37542 37551. (Pubitemid 32004863)
21. Hollingsworth E. B., McCeal E. T., Burton J. L., Williams R. J., Daly J. W. Creveling C. R. (1985) Biochemical characterization of filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3′:5′-monophosphate-generating systems, receptors and enzymes. J. Neurosci. 5, 2240 2253. (Pubitemid 15011005)
22. Hornykiewicz O. (2006) The discovery of dopamine deficiency in the parkinsonian brain. J. Neural. Transm. Suppl. 70, 9 15. (Pubitemid 44622172)
23. Hornykiewicz O. Kish S. J. (1986) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 19 34.
24. 2 are resistant to MPTP neurotoxicity. J. Neurochem. 71, 2634 2637. (Pubitemid 28531277)
25. 2 in dopamine secretion by rat neuronal PC cells. J. Lipid Mediat. Cell Signal. 14, 25 31. (Pubitemid 26343333)
26. Kukreja R. C., Kontos H. A., Hess M. L. Ellis E. F. (1986) PGH synthase and lipooxygenase generate superoxide in the presence of NADH or NADPH. Cric. Res. 59, 612 619. (Pubitemid 17035305)
27. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680 685.
28. 2 is phosphorylated and activated by MAP kinase. Cell 72, 269 278.
29. Lynch M. A., Clements M. P., Voss K. L., Bramham C. R. Bliss T. V. P. (1991) Is arachidonic acid a retrograde messenger in long- term potentiation? Biochem. Soc. Trans. 19, 391 396.
30. Molloy G. Y., Rattray M. Willams R. J. (1998) Genes encoding multiple forms of phospholipase A2 are expressed in rat brain. Neurosci. Lett. 258, 139 142. (Pubitemid 29023567)
31. 2. Clin. Rev. Immunol. 17, 225 283. (Pubitemid 27268457)
32. 2. J. Biol. Chem. 276, 39653 39660.
33. Mytilineou C., Kramer B. C. Yabut J. A. (2002) Glutathione depletion and oxidative stress. Parkinsonism Relat. Disord. 8, 385 387. (Pubitemid 36151653)
34. 2+-independent catalytic domain. J. Biol. Chem. 269, 18239 18249.
35. Notides A. Gorski J. (1966) Estrogen-induced synthesis of a specific uterine protein. Proc. Natl Acad. Sci. USA 56, 230 235.
36. Phillis J. W. O'Regan M. H. (2004) A potentially critical role of phospholipases in central nervous system ischemic, traumatic and neurodegenerative disorders. Brain Res. 44, 13 47. (Pubitemid 38114757)
37. Przedborski S., Jackson-Lewis V., Yokoyama R., Shibata T., Dawson V. L. Dawson T. M. (1996) Role of neuronal nitric oxide in 1-methyl-phenyl-1,2,3,6- tetrahydropirydine (MPTP)-induced dopaminergic neurotoxicity. Proc. Natl Acad. Sci. USA 93, 4565 4571.
38. 2. J. Biol. Chem. 273, 8203 8211.
39. Samanta S., Perkinton M., Morgan M. Williams R. J. (1998) Hydrogen peroxide enhances signal-responsive arachidonic acid release from neurons: role of mitogen-activated protein kinase. J. Neurochem. 70, 2082 2090. (Pubitemid 28207832)
40. Schapira A. H. V. (1996) Oxidative stress in Parkinson's disease. Neuropathol. Appl. Neurobiol. 21, 3 9.
41. Shelat P. B., Chalimoniuk M., Wang J.-H., Strosznajder J. B., Lee J. C., Sun A. Y., Simonyi A. Sun G. Y. (2008) Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A(2) in cortical neurons. J. Neurochem. 106, 45 55. (Pubitemid 351840199)
42. Six D. A. Dennis E. A. (2000) The expending superfamily of phospholipase A enzymes: classification and characterization. Biochem. Biophys. Acta 1488, 1 19. (Pubitemid 30842575)
43. Sonsalla P. K., Albers D. S. Zeevalk G. D. (1998) Role of glutamate in neurodegeneration of dopamine neurons in several animals model of parkinsonism. Amino Acid 14, 69 74. (Pubitemid 28051154)
44. 2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45, 205 213. (Pubitemid 38228817)
45. Tariq M., Khan H. A., Al Moutaery K. Al Deeb S. (2001) Protective effect of quinacrine on striatal dopamine levels in 6-OHDA and MPTP models of Parkinsonism in rodents. Brain Res. Bull. 54, 77 82. (Pubitemid 32156918)
46. Toborek M., Malecki A., Garrido R., Mattson M. P., Hening B. Young B. (1999) Arachidonic acid-induced injury to cultured spinal cord neurons. J. Neurochem. 73, 684 694.
47. Wang X. Robinson P. J. (1997) Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system. J. Neurochem. 68, 443 456. (Pubitemid 27044703)
48. 2-mediated arachidonic acid release by P2Y receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and independent pathways. J. Clin. Invest. 99, 805 814. (Pubitemid 27097685)
49. 2 phosphorylation and arachidonic acid release in primary murine astrocytes. J. Neurochem. 83, 259 270. (Pubitemid 35191392)
50. Xu J., Chalimoniuk M., Shu Y., Simonyi A., Sun A. Y., Gonzalez F. A., Weisman G. A., Wood W. G. Sun G. Y. (2004) Prostaglandin E2 production in astrocytes: regulation by cytokines, extracellular ATP, and oxidative agents. Prostoglandins Leukot. Essent. Fatty Acids 69, 437 448.
51. Zhang Y., Dawson V. L. Dawson T. M. (2000) Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7, 240 250.